Inoculating infants instead of adults could bypass problem, researchers say
July 30, 2015
| By Dr. Rachel Tompa / Fred Hutch News Service
New findings suggest that the gut microbiome’s influence on the childhood immune system may be the reason a promising experimental HIV vaccine failed to protect people from infection with the virus in recent clinical trials.
Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies
April 9, 2012
Fred Hutchinson Cancer Research Center researchers played a key role in the discovery of important immune responses that may have protected some volunteers from HIV in the RV144 Thai trial, the first HIV vaccine trial to show modest effectiveness in preventing HIV infection. Results from extensive RV144 laboratory studies were published April 5 in the New England Journal of Medicine.